{"id":51921,"date":"2012-01-19T11:54:31","date_gmt":"2012-01-19T16:54:31","guid":{"rendered":"https:\/\/www.bates.edu\/news\/?p=51921"},"modified":"2018-10-01T13:40:27","modified_gmt":"2018-10-01T17:40:27","slug":"marketwatch-bonney-80-top-ceo","status":"publish","type":"post","link":"https:\/\/www.bates.edu\/news\/2012\/01\/19\/marketwatch-bonney-80-top-ceo\/","title":{"rendered":"Bates board chair Bonney ’80 named a top U.S. CEO by MarketWatch"},"content":{"rendered":"

In his day job, Mike Bonney \u2014 a 1980 Bates graduate who chairs the college\u2019s Board of Trustees \u2014 is chief executive officer of Cubist Pharmaceuticals Inc., one of the leading companies in its field.<\/p>\n

He\u2019s also one of the six best corporate leaders in the country, in the view of MarketWatch<\/em>, a leading financial news source published by Dow Jones & Co., which also publishes The Wall Street Journal<\/em>.<\/p>\n

\"\"<\/a>

Michael Bonney ’80, chair of the college’s Board of Trustees, was recently named a top U.S. CEO by MarketWatch.<\/p><\/div>\n

On Jan. 17, MarketWatch announced the results of its 2011 CEO of the Year award,<\/a> profiling not only winner Jeff Bezos, CEO of Amazon.com, but also the other five finalists: Bonney; Dell Inc. CEO Michael Dell; Whole Foods Market\u2019s co-CEOs John Mackey and Walter Robb; and Electronic Arts\u2019 CEO John Riccitiello.<\/p>\n

In its profile of Bonney,<\/a> MarketWatch<\/em> writes that since joining Cubist in 2002, \u201cBonney has ended up having a tremendous impact on the Lexington, Mass.\u2013based firm, which specializes in antibiotics for so-called superbugs, bacterial strains that have grown resistant to traditional antibiotics and have emerged as a significant threat to public health in recent years.\u201d<\/p>\n

The online publication lauds Bonney for \u201chis leadership in safeguarding Cubist\u2019s primary money maker, for moves that bolstered the company\u2019s product pipeline, and for his open and encouraging management style.\u201d<\/p>\n

\u201cCubist executives say much of Bonney\u2019s success can be credited to his low-key demeanor and informal management style,\u201d MarketWatch adds. \u201cBonney, they say, frowns on game playing and encourages employees to voice their opinions.\u201d<\/p>\n

The MarketWatch articles do not delve into the undergraduate educations of the executives profiled, but Bonney is happy to say how his Bates education helped develop his talents and contributed to his success.<\/p>\n

\u201cMy experiences as a student at Bates really established my interest in learning as well as provided me the opportunity to expand my horizons beyond Maine,\u201d Bonney says.<\/p>\n

\"\"<\/a>

Mike Bonney ’80 presents a symbolic key to Roger Williams Hall to Spanish professor Claudia Aburto Guzm\u00e1n during dedication festivities for Roger Williams and Hedge halls. Photograph by Rene Minnis.<\/p><\/div>\n

In a November 2011 interview<\/a> with New England Cable News, Bonney explained how that interest in learning has influenced in his business career.<\/p>\n

\u201cEarly in my career I was offered what would have been considered to be nontraditional opportunities,\u201d he said. \u201cMany of my peers would have said, \u2018I don\u2019t want to do that,\u2019 because those jobs took you out of the silo of a traditional path. I said, \u2018This is an opportunity to learn something new, to have a new perspective on the business.\u2019 That has allowed me to develop a greater breadth of understanding of how our business works, how we interact with regulators and with physicians and patients, which ultimately has been very helpful.<\/p>\n

\u201cI ask a lot of questions. I am a lifelong learner\u2026. I will dive into any subject matter even though I have no reason to expect that I can learn it. And I try to figure out what it all means. Depth of experience is important. But for my money, having a broad perspective on the world is more important.\u201d<\/p>\n

Bonney has been a member of the Bates board since 2002 and was elected to chair the board in 2010.<\/p>\n

He and his family have many strong connections to Bates. His grandfather attended Bates and his father, sister, wife and oldest daughter are all Bates graduates. Another daughter is a member of the Class of 2012 and his son is a member of the Class of 2015. Both Bonney and his wife, Alison Grott Bonney \u201980, have been very active in service to Bates.<\/p>\n

After graduating from Bates with a degree in economics, Bonney began his career with Maine-based Hannaford Brothers, working in the supermarket chain\u2019s pharmacy operation. He later joined Zeneca Pharmaceuticals, holding positions of increasing responsibility in sales, marketing and strategic planning over the course of 11 years.<\/p>\n

In 1995 he joined Biogen Inc., ultimately serving as vice president for sales and marketing. He joined Cubist as president and chief operating officer, and has been president, chief executive officer and a member of the Board of Directors since 2003.<\/p>\n

In 2010, the Massachusetts Biotechnology Council recognized Bonney\u2019s accomplishments in his professional field by presenting him its second annual Innovative Leadership Award, which honors an industry executive who represents a company with a strong presence in and commitment to growing in Massachusetts.<\/p>\n

Bonney\u00a0is a director of the biopharmaceutical company NPS Pharmaceuticals Inc. and\u00a0a member of the board of the Pharmaceutical Research and Manufacturers of America.\u00a0He is a former board member of the Biotechnology Industry Organization.<\/p>\n","protected":false},"excerpt":{"rendered":"

Bates board chair Mike Bonney ’80, CEO of Cubist Pharmaceuticals Inc., is one of the six best corporate leaders in the U.S., according to a leading financial news publication.<\/p>\n","protected":false},"author":148,"featured_media":51928,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_hide_ai_chatbot":false,"_ai_chatbot_style":"","associated_faculty":[],"_Page_Specific_Css":"","_bates_restrict_mod":false,"_table_of_contents_display":false,"_table_of_contents_location":"","_table_of_contents_disableSticky":false,"_is_featured":false,"footnotes":"","_bates_seo_meta_description":"","_bates_seo_block_robots":false,"_bates_seo_sharing_image_id":0,"_bates_seo_sharing_image_twitter_id":0,"_bates_seo_share_title":"","_bates_seo_canonical_overwrite":"","_bates_seo_twitter_template":""},"categories":[217,11009],"tags":[8840,11051,4110,5825],"class_list":["post-51921","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-technology","category-the-college","tag-bates-board-of-trustees","tag-bates-in-the-news","tag-healthcare","tag-medicine"],"_links":{"self":[{"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/posts\/51921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/users\/148"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/comments?post=51921"}],"version-history":[{"count":18,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/posts\/51921\/revisions"}],"predecessor-version":[{"id":118965,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/posts\/51921\/revisions\/118965"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/media\/51928"}],"wp:attachment":[{"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/media?parent=51921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/categories?post=51921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bates.edu\/news\/wp-json\/wp\/v2\/tags?post=51921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}